Work

Performance Evaluation and Validation of a Next-Generation Sequencing-Based Measurable Residual Disease Assay for FLT3 Internal Tandem Duplication Detection in Acute Myeloid Leukemia

Year: 2026
Type: article
Abstract: Background: -ITDs) in measurable residual disease (MRD) remains challenging due to structural heterogeneity and the limited sensitivity of conventional methods. Methods: -ITDs in AML. Results: -ITD clones identified in 35.0% of patients and frequent detection of low-level microclones. Longitudinal analysis further revealed diverse clonal dynamics. Conclusions: -ITDs and enables high-resolution assessment of clonal dynamics, supporting its clinical utility for MRD monitoring in AML.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7225419582
FWCI:
Cites:
Cited by:
Related to: 10